New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
Diana Domnitei, Vishal MadaanDepartment of Psychiatry, Creighton University Medical Center, Omaha, NE, USAAbstract: Treatment guidelines from the American Academy of Child and Adolescent Psychiatry and the American Academy of Pediatrics state that stimulant medications have the most evidence for saf...
Enregistré dans:
Auteurs principaux: | Diana Domnitei, Vishal Madaan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2010
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/76a7b95d9d09471b84ee133aa3c5f411 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Update on optimal use of lisdexamfetamine in the treatment of ADHD
par: Madaan V, et autres
Publié: (2013) -
Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
par: Weisler RH, et autres
Publié: (2013) -
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
par: Michael Pennick
Publié: (2010) -
Physician perception of clinical improvement in children with attention-deficit/hyperactivity disorder: a post hoc comparison of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in a crossover analog classroom study
par: López F, et autres
Publié: (2011) -
Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults
par: Ermer J, et autres
Publié: (2013)